Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Warfarin (a CYP2C9 substrate), certain statins, and some calcium channel blockers are examples where an interaction would be drug-resveratrol, not resveratrol-tirzepatide
It's a dual GLP-1 and GIP receptor agonist
Novo is also testing GLP-1s for Alzheimers disease
Tirzepatide is a novel dual agonist medication that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors
This product is not intended to diagnose, treat, cure, or prevent any disease, and individual results may vary
US$ 28.09
US$ 20.94
US$ 25.81
